27 Nov 2025 Obulytix Strengthens Senior Leadership with Key Executive and Board Appointments Multiple categories
25 Nov 2025 Allegro and American Regent sign exclusive licensing deal for SynoglideTM, a novel osteoarthritis treatment in animal health, valued at up to $35 million Multiple categories
19 Nov 2025 P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence Multiple categories
12 Nov 2025 BIO INX and Yamato Scientific Announce Strategic Partnership for Distribution in Japan Multiple categories
08 Oct 2025 Confo Therapeutics awarded VLAIO grant for development of ultra-long-acting antibody-based GPCR therapeutics in endocrine and metabolic conditions Multiple categories
07 Oct 2025 Biovia supports ALCOVE: early lung cancer detection through breath analysis Multiple categories
06 Oct 2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
